Interleukin-18 and interleukin-1β: Two cytokine substrates for ICE (caspase-1)

Journal of Clinical Immunology

Volumn 19, Issue 1, 1999, Pages 1-11

  Fantuzzi, Giamila ^a,b   Dinarello, Charles A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Caspases; Cytokines; Interleukin 1; Interleukin 18; Processing enzymes; Proteinase 3

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN RECEPTOR;

ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0032909752     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020506300324     Document Type: Article

References (119)

1. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 87:2095-2147, 1996
2. Zhang Y, Center DM, Wu DMH, Cruikshank WW, Yuan J, Andrews DW, Kornfeld H: Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem 273:1144-1149, 1998
3. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, Kurimoto M, Tanimoto T, Flavell RA, Sato V, Harding MW, Livingston DL, Su MS-S: Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275:206-209, 1997
4. Clark-Lewis I, Schumacher C, Baggiolini M, Moser B: J Biol Chem 266:23128-23134, 1991
5. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Schmidt JA, Tocci M: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768-774, 1992
6. Howard AD, Kostura MJ, Thornberry N, Ding GJF, Limjuco G, Weidner J, Salley JP, Hogquist KA, Chaplin DD, Mumford RA, Schmidt JA, Tocci MJ: IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1β precursor at two distinct sites and does not cleave 31-KDa IL-1α. J Immunol 147:2964-2969, 1991
7. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, Wong W, Kamen R, Tracey D, Allen H: Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619-623, 1997
8. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP: A metalloproteinase disintegrin that releases tumour necrosis factor-α from cells. Nature 385:729-733, 1997
9. Moss ML, Jin CS-L, Milla ME, Burkhart W, Carter HL, Chen W-J, Clay WC, Didsbury JR, Hassler D, Hoffman C, Kost TA, Lambert MH, Leesnitzer A, McCauley P, McGeehan G, Mitchell J, Moyers M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su J-L, Warner J, Willard D, Becherer JD: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733-736, 1997
10. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, Raybuck SA, Livingston DJ: Structure and mechanism of interleukin-1β converting enzyme. Nature 370:270-275, 1994
11. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 87:123, 1996
12. Walker NP, Talanian RV, Brady KD, Dang LC, Bump NJ, Ferenz CR, Franklin S, Ghayur T, Hackett MC, Hammill LD: Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: A (p20/p10)2 homodimer. Cell 78:343-352, 1994
13. Puren AJ, Fantuzzi G, Dinarello CA: Gene expression, synthesis and secretion of IL-1β and IL-18 are differentially regulated in human blood mononuclear cells and mouse spleen cells. Eur Cytokine Netw 9(abstract), 1998
14. Akita K, Ohtsuki T, Nukada Y, Tanimoto T, Namba M, Okura T, Takakura-Yamamoto R, Torigoe K, Gu Y, Su MS-S, Fuji M, Satoh-Itoh M, Yamamoto K, Kohno K, Ikeda M, Kurimoto M: Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin-18 in monocytic THP.1 cells. J Biol Chem 272:26595-26606, 1997
15. Li J, Billiar TR, Talanian RV, Kim YM: Nitric oxide inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240:419-422, 1997
16. Dimmeler S, Haendeler J, Nehls M, Zeiher AM: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 185:601-606, 1997
17. Kim Y-M, Talanian RV, Li J, Billiar TR: Nitric oxide prevents IL-1β and IFN-γ-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1β-converting enzyme). J Immunol 161:4122-4128, 1998
18. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J, Towne E, Tracey D, Wardwell S, Wei F-Y, Wong W, Kamen R, Seshadri T: Mice deficient in interleukin-1 converting enzyme (ICE) are detective in production of mature interleukin-1β and resistant to endotoxic shock. Cell 80:401-411, 1995
19. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS-S, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267: 2000-2003, 1995
20. Fantuzzi G, Zheng H, Faggioni R, Benigni F, Ghezzi P, Sipe JD, Shaw AR, Dinarello CA: Effect of endotoxin in IL-1β-deficient mice. J Immunol 157:291-296, 1996
21. Fantuzzi G, Puren AJ, Harding MW, Livingston DJ, Dinarello CA: Interleukin-18 regulation of interferon γ production and cell proliferation as shown in interleukin-1β-converting enzyme (caspase-1)-deficient mice. Blood 91:2118-2125, 1998
22. Thronberry NA, Lazebnik Y: Caspases: Enemies within. Science 281:1312-1316, 1998
23. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS, Wignall J, Conlon PJ, Cosman D, Hopp TP: Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 263:9437-9442, 1988
24. Dinarello CA, Cannon JG, Mier JW, Bernheim HA, LoPreste G, Lynn DL, Love RN, Webb AC, Auron PE, Reuben RC, Rich A, Wolff SM, Putney SD: Multiple biological activities of human recombinant interleukin 1. J Clin Invest 77:1734-1739, 1986
25. Hazuda DJ, Strickler J, Kueppers F, Simon PL, Young PR: Processing of precursor interleukin-1 beta and inflammatory disease. J Biol Chem 265:6318-6322, 1990
26. Irmler M, Hertig S, MacDonald HR, Sadoul R, Becherer JD, Proudfoot A, Solari R, Tschopp J: Granzyme A is an interleukin-1β-converting enzyme. J Exp Med 181:1917-1922, 1995
27. Knudsen PJ, Dinarello CA, Strom TB: Purification and characterization of a unique human interleukin 1 from the tumor cell line U937. J Immunol 136:3311-3316, 1986
28. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS: Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cells chymase. J Exp Med 174:821-825, 1991
29. Schoenbeck U, Mach F, Libby P: Generation of biologically active IL-1β by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1β processing. J Immunol 161:3340-3346, 1998
30. Beuscher HU, Guenther C, Roellinghoff M: IL-1β is secreted by activated murine macrophages as biologically inactive precursor. J Immunol 144:2179-2183, 1990
31. Hazuda DJ, Lee JC, Young PR: The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem 263:8473-8479, 1988
32. Robache-Gallea S, Morand S, Bruneau JM, Schoot B, Tagat E, Realo E, Chouaib S, Roman-Roman S: In vitro processing of human tumor necrosis factor-α. J Biol Chem 270:23688-23692, 1995
33. Nakamura K, Komiya M: Proteolysis of human tumor necrosis factor (TNF) by endo- and exopeptidases: process of proteolysis and formation of active fragments. Biol Pharm Bull 19:672-677, 1996
34. Padrines M, Wolf M, Walz A, Baggiolini M: Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett 352:231-235, 1994
35. Leavell KJ, Peterson MW, Gross TJ: Human neutrophil elastase abolishes interleukin-8 chemotactic activity. J Leukoc Biol 61: 361-366, 1997
36. Kekow J, Csernok E, Szymkowiak C, Gross WL: Interaction of transforming growth factor beta (TGF beta) with proteinase 3. Adv Exp Med Biol 421:307-313, 1997
37. Longley BJ, Tyrrell L, Ma Y, Williams DA, Halaban R, Langley K, Lu HS, Schehter NM: Chymase clavage of stem cell factor yields a bioactive, soluble product. Proc Natl Acad Sci USA 94:9017-9021, 1997
38. Duval-Jobe C, Leeson M, Rawitch A, Parmely MJ: Mechanism by which U937 promonocytic cells inactivate human interferon-gamma. J Interferon Cytokine Res 15:557-567, 1995
39. Ku G, Faust T, Lauffer LL, Livingtson DJ, Harding MW: Interleukin-1β converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine 8:377-386, 1996
40. Norman J, Yang J, Fink G, Carter G, Ku G, Denham W, Livingston D: Severity and mortality of experimental pancreatitis are dependent on interleukin-1 converting enzyme (ICE). J Interferon Cytokine Res 17:113-118, 1997
41. Zheng H, Fletcher D, Kozak W, Jiang M, Hofmann K, Conn CC, Siszynski D, Grabiec C, Trumbauer MA, Shaw AR, Kostura MJ, Stevens K, Rosen H, North RJ, Chen HY, Tocci MJ, Kluger MJ, Van der Ploeg LHT: Resistance to fever induction and impaired acute-phase response in interleukin-1β deficient mice. Immunity 3:9-19, 1995
42. Fantuzzi G, Dinarello CA: The inflammatory response in interleukin-1β-deficient mice: Comparison with other cytokine-related knock-out mice. J Leukoc Biol 59:489-493, 1996
43. Spector WG, Willoughby DA: The demonstration of the role of mediators in turpentine pleurisy in rats by experimental suppression of the inflammatory changes. J Pathol Bacteriol 77:1-17, 1959
44. Mariano M, Araujo VC: Relation between diaphragmatic mast-cell activity and exudate formation in acute experimental pleurisy. J Pathol 104:275-281, 1971
45. Williams DM, Johnson NW: Early colonisation of a local inflammatory lesion and its relationship to changes in systemic leucocyte availability: A study of turpentine-induced lesions in the rat. J Pathol 125:139-149, 1978
46. Fantuzzi G, Ku G, Harding MW, Livingston DL, Sipe JD, Kuida K, Flavell RA, Dinarello CA: Response to local inflammation of IL-1β converting enzyme-deficient mice. J Immunol 158:1818-1824, 1997
47. Nylander Lundqvist E, Egelrud T: Biologically active, alternatively processed interleukin-1b in psoriatic scales. Eur J Immunol 27:2165-2171, 1997
48. Nylander-Lundqvist E, Egelrud T: Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm Venereol 77:203-206, 1997
49. Murakami K, Kobayashi F, Ikegawa R, Koyama M, Shintani N, Yoshida T, Nakamura N, Kondo T: A metalloproteinase inhibitor prevents hepatic injury in endotoxemic mice. Eur J Pharmacol 341:105-110, 1998
50. Solorzano CC, Ksontini R, Pruitt JH, Auffenberg T, Tannahill C, Galardy RE, Schultz GP, MacKay SL, Copeland EMr, Moldawer LL: A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. Shock 7:427-431, 1997
51. Liedtke W, Cannella B, Mazzaccaro RJ, Clements JM, Miller KM, Wucherpfennig KW, Gearing AJ, Raine CS: Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann Neurol 44:35-46, 1998
52. Niehorster M, Tiegs G, Schade UF, Wendel A: In vivo evidence for protease-catalysed mechanisms providing bioactive tumor necrosis factor α. Biochem Pharmacol 40:1601-1603, 1990
53. Scuderi P, Dorr RT, Liddil JD, Finley PR, Meltzer P, Raitano AB, Rybski J: Alpha-globulins suppress human leukocyte tumor necrosis factor secretion. Eur J Immunol 19:939-942, 1989
54. Fantuzzi G, Karasek JA, Reznikov LL, Puren AJ, Cheronis J, Dinarello CA: A role for neutrophil proteinase-3 (PR-3) in the generation of active IL-18. Eur Cytokine Netw 9(abstract), 1998
55. Campanelli D, Melchior M, Fu Y, Nakata M, Shuman H, Nathan C, Gabay JE: Cloning of cDNA for proteinase 3: A serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 172:1709-1715, 1990
56. Mayet W-J, Csernok E, Szymkowiak C, Gross WL, Meyer zum Buschenfelde K-K: Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 82:1221-1229, 1993
57. Csernok E, Ludemann J, Gross WL, Bainton DF: Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am J Pathol 137:1113-1120, 1990
58. Braun MG, Csernok E, Gross WL, Muller-Hermelink HK: Proteinase-3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathological tissues. Am J Pathol 139:831-838, 1991
59. Bergenfeldt M, Axelsson L, Ohlsson K: Release of neutrophil proteinase 4 (3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors. Scand J Clin Lab Invest 52:823-829, 1992
60. Ralston DR, Marsh CB, Lowe MP, Wevers MD: Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, αl-antitrypsin, and Fcγ receptors. J Clin Invest 100:1416-1424, 1997
61. Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL: Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 95:244-250, 1994
62. Baslund B, Petersen J, Permin H, Wiik A, Wieslander J: Measurement of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. J Immunol Methods 175:215-225, 1994
63. Henshaw TJ, Malone CC, Gabay JE, Williams RCJ: Elevations of neutrophil proteinase 3 in serum of patients with Wegener's granulomatosis and polyarteritis nodosa. Arthr Rheum 37:104-112, 1994
64. Dolman KM, van de Wiel BA, Kam C-M, Abbink JJ, Hack CE, Sonnenberg A, Powers JC, von dem Borne AEGK, Goldschmeding R: Determination of proteinase-3-α1-antitrypsin complexes in inflammatory fluids. FEBS Lett 314:117-121, 1992
65. Lundberg E, Bergenfeldt M, Ohlsson K: Release of immunoreactive neutrophil proteinase 4, normally and in peritonitis. Scand J Clin Lab Invest 51:23-29, 1991
66. Jonsson P: Cardropulmonary bypass causes release of leukocyte proteinase-3. Scand J Clin Lab Invest 56:721-723, 1996
67. Elneihoum AM, Falke P, Axelsson L, Lundberg BS, Lindgarde F, Ohlsson K: Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 27:1734-1738, 1996
68. Regelmann WE, Herron J, Seifferman C, Gray B, Elliott GR, Clawson CC: Increased sputum peroxidase activity is associated with increased pulmonary disease in cystic fibrosis. Am Rev Respir Dis 139:A70, 1989 (abstract)
69. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M: Cloning of a new cytokine that induces interferon-γ. Nature 378:88-91, 1995
70. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, Kaneda K: IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 157:3967-3973, 1996
71. 7!. Mileno MD, Margolis NH, Clark BD, Dinarello CA, Burke JF, Gelfand JA: Coagulation of whole blood stimulates interleukin-1β gene expression: Absence of gene transcripts in anticoagulated blood. J Infect Dis 172:308-311, 1995
72. Shapiro L, Dinarello CA: Cytokine expression during osmotic stress. Exp Cell Res 231:354-362, 1997
73. Tone M, Thompson SAJ, Tone Y, Fairchild PJ, Waldmann H: Regulation of IL-18 (IFN-γ-inducing factor) gene expression. J Immunol 159:6156-6163, 1997
74. Chupp GL, Wright EA, Wu D, Vallen-Mashikian M, Cruikshank WW, Center DM, Kornfeld H, Berman JS: Tissue and T cell distribution of precursor and mature IL-16. J Immunol 161:3114-3119, 1998
75. Stoll S, Mueller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J, Enk AH: Production of IL-18 (IFN-γ-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 159:298-302, 1997
76. Xu B, Aoyama K, Yu S, Kitani A, Okamura H, Kurimoto M, Matsuyama T, Matsushita T: Expression of interleukin-18 in murine contact hypersensitivity. J Interferon Cytokine Res 18: 653-659, 1998
77. Conti B, Jeong JW, Tinti C, Son JH, Joh TH: Induction of IFN-γ-inducing factor in the adrenal cortex. J Biol Chem 272: 2035-2037, 1997
78. Udagawa N, Horwood NJ, Elliot J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Gillespie MT: Interleukin-18 is produced by osteoblasts and acts via granulocyte macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation. J Exp Med 185:1005-1012, 1997
79. Martin TJ, Romas E, Gillespie MT: Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 8:107-123, 1998
80. Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikate T, Murakami T, Sanou O, Kojima H, Fuji M, Ohta T, Ikeda M, Ikegami H, Kurimoto M: Purification and characterization of the human interleukin-18 receptor. J Biol Chem 272:25737-25742, 1997
81. Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE: IL-1 Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J Biol Chem 271:3967-3970, 1996
82. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K: IL-12 upregulates IL-18 receptor expression on T cells, Th 1 cells and B cells: Synergism with IL-18 for IFNγ production. J Immunol 161:3400-3407, 1998
83. Born TL, Thomassen E, Bird TA, Sims JE: Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 273:29445-29450, 1998
84. Novick D, Kim S-H, Fantuzzi G, Reznikov L, Dinarello CA, Rubinstein M: A circulating IL-18 binding protein: Isolation and characterization. Eur Cytokine Netw 9(abstract), 1998
85. Kim S-H, Novick D, Fantuzzi G, Reznikov L, Dinarello CA, Rubinstein M: The interleukin-18 binding protein is a decoy receptor lacking a transmembrane domain. Eur Cytokine Netw 9(abstract), 1998
86. Rubinstein M, Novick D, Kim S-H, Fantuzzi G, Reznikov L, Dinarello CA: A family of poxvirus-encoded homologues of the interleukin-18 binding protein. Eur Cytokine Netw 9(abstract), 1998
87. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G: Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J Biol Chem 270:13757-13765, 1995
88. Croston GE, Cao Z, Goeddel DV: NFkB activation by interleukin-1 requires an IL-1 receptor-associated protein kinase activity. J Biol Chem 270:16514-16517, 1995
89. Martin MU, Falk W: The interleukin-1 receptor complex and interleukin-1 signal transduction. Eur Cytokine Netw 8:5-17, 1997
90. O'Neill LAJ, Greene C: Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63:650-657, 1998
91. Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU: The interleukin-1 receptor accessory protein is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 272:7727-7731, 1997
92. Huang J, Gao X, Li S, Cao Z: Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA 94:12829-12832, 1997
93. Cao Z: Signal transduction of interleukin-1. Cytokine, 1998 (in press)
94. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV: IRAK TRAF-6. Nature 383:443-446, 1996
95. Malinin NL, Boldin MP, Kovalenko AV, Wallach D: MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385:540-544, 1997
96. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M: A cytokine-responsive I kappaB kinase that activates the transcription factor NF-kappaB. Nature 388:548-554, 1997
97. Kojima H, Takeuchi M, Ohta T, Nishida Y, Arai N, Ikeda M, Ikegami H, Kurimoto M: Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem Biophys Res Commun 244:183-186, 1998
98. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A: IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571-581, 1997
99. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, Akira S: Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150, 1998
100. Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Su MS-S, Gu Y, Dinarello CA: Interleukin-18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci USA 95:12550-12555, 1998
101. Tsuji-Takayama K, Matsumoto S, Koide K, Takeuchi M, Ikedo M, Ohta T, Kurimoto M: Interleukin-18 induces activation and association of p56lck and MAPK in a murine TH1 clone. Biochem Biophys Res Commun 237:126-130, 1997
102. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-274, 1995
103. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto K, Okamura H, Nakanishi K, Akira S: Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-390, 1998
104. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Büschenfelde K-H, Neurath MF: IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-γ promotor in primary CD4+ T lymphocytes. J Immunol 160, 1998
105. Munder M, Mallo M, Eichmann K, Modolell M: Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med 187:2103-2108, 1998
106. Gu Y, Wu J, Faucheu C, Lalanne J-L, Diu A, Livingston DL, Su MS-S: Interleukin-1β converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J 14:1923-1931, 1995
107. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M: IFN-γ-inducing factor (IGIF) is a co-stimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158:1541-1550, 1997
108. Puren AJ, Fantuzzi G, Gu Y, Su MS-S, Dinarello CA: Interleukin-18 (IFN-γ-inducing factor) induces IL-1β and IL-8 via TNFα production from non-CD14+ human blood mononuclear cells. J Clin Invest 101:711-724, 1998
109. Matsimoto S, Tsuji-Takayama K, Aizawa Y, Koide K, Takeuchi M, Ohta T, Kurimoto M: Interleukin-18 activates NFkB in murine T helper type I cells. Biochem Biophys Res Commun 234:454-457, 1997
110. Netea MG, Kulberg BJ, Amiot F, van der Meer JWM: Preferential production of interleukin-6 and IL-1β by murine peritoneal macrophages exposed to IL-18: No role for TNF and lymphotoxin-α. Eur Cytokine Netw 9(abstract), 1998
111. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, Tanabe F, Konishi K, Mcallef M, Fujii M, Torigoe K, Tanimoto T, Fukuda S, Ikeda M, Okamura H, Kurimoto M: Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156:4274-4279, 1996
112. Micallef MJ, Ohtsuki T, Kohno K, Tanabe F, Ushio S, Namba M, Tanimoto T, Torigoe K, Fujii M, Ikeda M, Fukuda S, Kurimoto M: Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-γ production. Eur J Immunol 26:1647-1651, 1996
113. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, Akita K, Torigoe K, Okura T, Fukuda S, Kurimoto M: A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 63:3966-3972, 1995
114. Yoshimoto T, Okamura H, Tagawa Y-I, Iwakura Y, Nakanishi K: Interleukin-18 together with interleukin-12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc Natl Acad Sci USA 94:3948-3953, 1997
115. Lauwerys BR, Renauld JC, Houssiau FA: Inhibition of in vitro immunoglobulin production by IL-12 in murine chronic graft-vs.-host disease: Synergism with IL-18. Eur J Immunol 28:2017-2024, 1998
116. Ohtsuki T, Micallef MJ, Kohno K, Tanimoto T, Ikeda M, Kurimoto M: Interleukin-18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res 17:3253-3258, 1997
117. Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H: Interferon-γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper cells. Cell Immunol 173:230-235, 1997
118. Dao T, Mehal WZ, Crispe IN: IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 161:2217-2222, 1998
119. Kohka H, Yoshino T, Iwagaki H, Sakuma I, Tanimoto T, Matsuo Y, Kurimoto M, Orita K, Akagi T, Tanaka N: Interleukin-18/ interferon-γ-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol 64:519-527, 1998